Fruquintinib receives SFDA IND approval Starts Phase I Clinical Trial for the treatment of cancer // Chi-Med
News Archive
Previous Article   |   Next Article
Innovation Platform, RNS Announcements | 1 Feb 2011

Fruquintinib receives SFDA IND approval Starts Phase I Clinical Trial for the treatment of cancer

1 Item
a110201